chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had bad panic attack; I was very nervous about getting it; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (I had bad panic attack) and NERVOUSNESS (I was very nervous about getting it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PANIC ATTACK (I had bad panic attack) and NERVOUSNESS (I was very nervous about getting it). At the time of the report, PANIC ATTACK (I had bad panic attack) and NERVOUSNESS (I was very nervous about getting it) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021, contains no newinformation.
Patient presents to health department c/o pain in right shoulder. Patient previously received Pneumovax 23 (Lot M005286, Exp 10-08-2017) in this arm on 10-17-16. Advised patient some pain or discomfort in arm not uncommon and should resolve over time. Patient reports pain is more in her shoulder. Advised patient per VIS sheet this can be a side effect. Patient feels may be related to administration. Attempt to reassure patient but patient insistent may be related to administration. Patient reports pain does improve with application of ice and patient does have ROM. Patient voices no other c/o but wants to make sure our office notified. Noted and Nursing Administrator and Back-up Immunization Coordinator, also notified who advises no further action needed.
Fever peaking at 102.7; chills about 12 hours; nausea; aches. This all lasted until about 24 hours after the shot. The next 2 days I had a fever of about 100, then it went down to 99.   I have noticed a pattern. Each time I get another covid vaccine I?m sicker. Nothing much with the first shot. About 101 with the second shot. High 101s with the 3rd shot, with a longer recovery time. 102.7 with this shot, with another 4-day recovery time. One more symptom with this last shot: I went for a walk 2 days after the shot and was dizzy, so I cut the walk short. I have not had that symptom before.
DOSE OF JNJ VACCINE GIVEN 8-9  HOURS AFTER FIRST PUNCTURE; DOSE OF JNJ VACCINE GIVEN 8 TO 9  HOURS AFTER FIRST PUNCTURE AFTER RECOMMENDED SHELF LIFE LIMIT OF 6 HOURS IN FRIDGE; This spontaneous report received from a pharmacist concerned a 41 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 205a21a, and expiry: 23-JUN-2021) dose was not reported, administered on 08-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAY-2021, the subject experienced dose of JNJ vaccine given 8-9 hours after first puncture. On 09-MAY-2021, the subject experienced dose of JNJ vaccine given 8 to 9 hours after first puncture after recommended shelf life limit of 6 hours in fridge. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dose of JNJ vaccine given 8-9 hours after first puncture and dose of JNJ vaccine given 8 to 9 hours after first puncture after recommended shelf life limit of 6 hours in fridge was not reported. This report was non-serious.
05/17/2022 I called and was concerned about feeling tight in my chest still and had some post nasal drip. I was chopping it up to allergies but unsure. They wanted to do a COVID test, and within 40 min it was positive. Went home and did the numerous COVID tests at home but all were negative. The doctors followed up with me at home and told me to stay home and quarantine and I told them I was feeling fine other than the post nasal drip/whistling in the chest. Also, I was told it likely would've been worse without the vaccination. I did not have a fever or any other symptoms but post nasal drip and a slight wheezy cough. Still having the post nasal drip to this day.
Acute myositis; weakness; difficulty standing; pain in muscles upon touch; This spontaneous case was reported by a physician and describes the occurrence of MYOSITIS (Acute myositis), ASTHENIA (weakness), DYSSTASIA (difficulty standing) and MYALGIA (pain in muscles upon touch) in an 87-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Patient had no allergies (medications, food and other products) Patient have multiple orthopedic problems.  The patient's past medical history included COVID-19 (tested positive in Feb 2022) in February 2022. Concurrent medical conditions included Blood pressure high.    On 07-May-2022, the patient received fourth dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOSITIS (Acute myositis), ASTHENIA (weakness), DYSSTASIA (difficulty standing) and MYALGIA (pain in muscles upon touch). At the time of the report, MYOSITIS (Acute myositis), ASTHENIA (weakness), DYSSTASIA (difficulty standing) and MYALGIA (pain in muscles upon touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, SARS-CoV-2 test: positive (Positive) positive. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant information were reported by the reporter. No treatment information were reported by the reporter.   This case was linked to MOD-2022-564775 (Patient Link).
Hives started appearing 1 day after shot.  By Wed (3 days after shot), red bumps all over trunk.  Bumps have red circle the size of a dime with a yellow "head" in the middle. Spots look similar to varicella zoster, so he is going to get tested.
This case was reported in a literature article and described the occurrence of anti-neutrophil cytoplasmic antibody positive vasculitis in a 67-year-old female subject who was vaccinated with influenza (unspecified), manufacturer unspecified). Concurrent medical conditions included anti-neutrophil cytoplasmic antibody positive vasculitis. On an unspecified date, the subject received unspecified dose of influenza (unspecified) (unknown route, site of injection and batch number). 12 days after vaccination with influenza (unspecified), the subject experienced a relapse of anti-neutrophil cytoplasmic antibody positive vasculitis (cytoplasmic/proteinase 3) and granulomatosis with polyangiitis. The organs involved were the kidney and the lung. This case was assessed as medically serious by GSK. The subject was treated with cyclophosphamide and prednisone. At the time of reporting, the subject was in remission. This case is linked to 7 cases coming from the same publication.
Day of  shot: April 13: Nausea, diarrhea, sore arm near injection site   Day after shot Apr 14: nausea, diarrhea, overall body aches, arm more sore than the day before, headache, fever 99.9, skin feels like it is on fire It?s at night so I haven?t visited my doctor. If the symptoms persist in the morning, I will call my doctor for advice.
Rash on left arm started about 2inx2in but not perfectly circular.  Was itchy, red,  hot to touch, & firm. By the 3rd day, rash was more spread out 3inx2in, less red & warm but with a red rim around the rash. Same level of itchiness.
having 1 missed period; having a heavy flow period; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (having 1 missed period) and HEAVY MENSTRUAL BLEEDING (having a heavy flow period) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AMENORRHOEA (having 1 missed period) and HEAVY MENSTRUAL BLEEDING (having a heavy flow period). At the time of the report, AMENORRHOEA (having 1 missed period) and HEAVY MENSTRUAL BLEEDING (having a heavy flow period) outcome was unknown.            No relevant concomitant medications was reported.  Treatment information was not provided.
Immediately following vaccination pt felt like he was going to pass out. Pt experienced LOC in the chair with significant other at side. Pt was safely lowered to floor by staff. Pt regained consciousness while on floor. Per staff LOC duration was 10 sec. Pt then transported to med obs at 0943 via stretcher. Pt reports dizziness and nausea. Pt placed in reverse trendelenburg position. Pt was slowly transitioned to a sitting position. Water and goldfish given. Nausea returned. Pt back to lying position. Pt feeling better and again slowly transitioned to a sitting and then standing position. Pt reports feeling fatigued but all other symptoms resolved. Pt released to home with significant other driving at 1054. Pt escorted to exit by staff and significant other with no further issues. Vitals as follows: 0945 BP 128/78 HR 57 SPO2 99 0950 BP 134/82 HR 56 SPO2 100 0955 BP 124/82 HR 76 SPO2 100 1002 BP 129/85 HR 62 SPO2 99 1001 BP 126/85 HR 64 SPO2 100 1015 SITTING BP 131/74 HR 69 SPO2 100 1030 SITTING BP 134/87 HR 73 1050 STANDING BP 121/82 HR 80 SPO2 100
Patient received the shot from intern and the injection site was slightly swelled up.  We asked her to check back with us 15 minutes later and the swelling was decreased. Patient said there was no pain.
Received Gardasil vaccine first, then HAV and within appx. 1 minute after vaccines client slumped to side while sitting in chair and was unresponsive for appx. 10 seconds. Staff assisted to floor and client became responsive prior to this. No injury occured. Given soda to drink. Client very thin. Oatmeal for breakfast but no dinner the night before. Blood pressure laying 104/60 Pulse 76. B.P.sitting 94/60 pulse 74
no adverse events; dose of PEDVAXHIB was administered following temperature excursions; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 12-MAR-2021, the patient was vaccinated with a dose of improper stored vaccine haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (0.5 mL, lot number S030967 has been verified to be a valid lot number, expiration date reported as 15-MAR-2022, but upon internal validation established as 15-APR-2022; strength and route of administration were not reported) for prophylaxis. It was reported that the vaccine was stored under 49.29 Fahrenheit for 15 minutes and was detected by data logger. There was no previous temperature excursion. No additional adverse event or product quality complaints were reported. No additional information was provided.
A few hours after the second dose was received both arms, stomach, and chest area all broke out in "itchy bumps" which has lasted now 2 months later in one spot on the injection arm.
Itchy skin without a rash on arms, hands and legs; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the left arm on 24Aug2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 03Aug2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 02Sep2021 at 11:00, the patient experienced itchy skin without a rash on her arms, hands, and legs. On 05Sep2021 (at the time of the report), the patient was still having it. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy skin without a rash on arms, hands and legs was not resolved at the time of this report.
20 minutes after the vaccine?Throat started feeling funny, then felt as if something was stuck in my throat and then voice stated sounding horse raspy. Slight dizziness in my head.
1 hour after injection developed abdominal cramping, nausea, headache, no emesis, this progressed later in evening to chills, face feeling hot and aching in neck muscles.  1st time lasted approximately 1 week this time only 4 days ago.  Symptoms continue.
Vivid dreams every night that result in interrupted sleep/wakefulness in the middle of the night.  This has occurred every night without fail (for more than 6 months straight) since the second dose of the Pfizer Covid shot, beginning the night the second shot was administered.  My doctor encouraged me to submit this report, as it was not one she had heard of before.
Severe chills (no fever), severe body tremors, severe muscle pain - all started at approx. 2230 day of injection. Chills resolved in two days, tremors resolved after medication received in emergency department, pain resolved after 3-4 days. Facial swelling, headache - began day after injection - headache resolved in two days. Swelling has decreased, but has not completely resolved.
Muscle Aches, Weakness, Pain at the right arm injection location, stomach cramps, diarrhea, mild dizziness or disorientation, lack of motivation to do anything except rest - even to reach for my phone that I dropped next to my bed amd respond to text notifications and phone calls, only getting up to go to the bathroom for the next 24 hours.
Child started screaming. Went limp, turned white, labored breathing them quit breathing. Lips and breast turned blue. Very lethargic, non responsive.
MD has noticed an inc incidence of hematomas @ the inject site following immun w/Tetramune; 1 of 5 pts (out of 10 pts immunized) who exp hematomas, approx 1 inch in diameter treated w/massage;
Increased heart rate; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Increased heart rate) and DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Increased heart rate) and DIZZINESS (Dizziness). At the time of the report, HEART RATE INCREASED (Increased heart rate) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.
This case was reported by a nurse via call center representative and described the occurrence of erythema of extremities in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was unknown. It was unknown if the reporter considered the erythema of extremities to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter is a retired registered nurse and stated that the pharmacist at the pharmacy where she received her SHINGRIX vaccine, informed her that approximately 30% of their patients complained of redness down their arm after receiving the SHINGRIX vaccine. This redness occurred on the same arm as the injection and was located below the injection site and down the arm. The nurse did not have any additional details regarding this event. This case has been linked to case US2018179263, reported by the same reporter for herself.
Temperature excursion occurred on  29-Nov-2022; No Adverse Event; Total of 16 doses were administered on 29-Nov-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Total of 16 doses were administered on 29-Nov-2022), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on  29-Nov-2022) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Nov-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Total of 16 doses were administered on 29-Nov-2022). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on  29-Nov-2022) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Total of 16 doses were administered on 29-Nov-2022), PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on  29-Nov-2022) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Total of 16 doses were administered on 29-Nov-2022) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on  29-Nov-2022).    No concomitant medications were reported. A total of 16 doses were administered on 29-Nov-2022 (5), 30-Nov-2022 (4), 1-Dec-2022 (2), 2-Dec-2022 (2), 3-Dec-2022 (1), and 5-Dec-2022.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-687892 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-687892:
Patient previously received the Pfizer Vaccine (does #1) at previous institution.  That vaccine is not offered at this facility. Patient meets the criteria to receive the 3rd dose of the vaccine.  It was not realized until after administration that he had previously received the Pfizer brand.  He has no adverse reactions at the current time.
01/27/2021- That afternoon, I started to feel feverish, temp was lightly elevated, I waited to treat the fever to see if it would raise or if it was nothing. Around 10pm it had raised to 101 and I developed body aches and chills, muscle aches and back pain, joint pain, fatigued, loss of appetite, it caused sleep issues, I started taking Tylenol and then rotated with ibuprofen , which brought temp to 100 but not back to normal, next day I finally fella sleep and slept for about 12 hours, when I woke my peak temp was 102.3, this would have been while the Tylenol and ibuprofen was no longer active in my system. I had a mild sore throat, slight post nasal drainage. A day or two after I saw the Dr. and was examined. No relief from Bromfed.
Severe dizziness, severe headache, severe nausea, constant chills, went to ER recieved tylenol by mouth after IV placed recieved IV fluids, benadryl,reglan and toradol  via IV. Headache became bearable,  nausea decreased . Next day I am still experiencing dizziness, headache and vaccine site continues to be swollen and very sore
HISTORY OF PRESENT ILLNESS:  The patient is a very pleasant previously healthy 22-year-old male, who just finished his second COVID vaccine on 07/07/2021 and developed chest pain, fever, nausea.  He presented to the ER where troponins were noted to be elevated, he was transferred here for further evaluation and treatment based on his cardiac condition and his insurance status.  HOSPITAL COURSE:  COVID-19 vaccine induced myopericarditis:  The patient was admitted to telemetry.  He was placed on colchicine. The doctor was kind enough to see the patient in consultation.  She recommended supportive care.  Echocardiogram showed preserved left ventricular function at this time.  It appears that the patient is tolerating the condition well; however, this is a very new clinical entity, so he will need close followup with cardiology.  I did ask the infectious disease nurse to notify the CDC that the patient did have this complication related to his vaccine, a known entity with COVID vaccination.
Mother reports veteran received vaccine and they returned home. Drive is approximately 2 hours. Mother noticed that veteran had noticeable swelling to bilateral lower extremities, especially in ankles and feet. Mother reports there was no swelling prior to vaccine. No other side effects noted by veteran. As of today, 04/05/2021, mother reports he still has swelling to lower extremities.
Within 24 hours large swelling at injection and hard ball under skin. Swelling proceeded to grow larger and larger over the next 7 days taking over top part of leg and thigh. Behavior was irritable, constant crying, screaming for 3-4 day straight. Not sleeping. Swelling went down on 7th day but additional rash broke out all over leg on 7th day.
Tingling and numbness in left shoulder and left side of neck for four days post first vaccine. Patient reports some pain at injection site on day of vaccination. Patient also reports some shortness of breath for the four days post vaccine.
Chills, body aches, fever. Developed a rash 2 days after shot on left arm where vaccination was administered.
Patient with borderline PD, PTSD, anxiety, depression and polysubstance abuse with opiates and amphetamines with intravenous use who presented to hospital reporting SI in the context of recent relationship fracture and ongoing difficulty managing her own medications at her group home. Patient was admitted to Behavioral Health unit for safety and stabilization. Hospital admission within 6 weeks of receiving the COVID vaccine.
General c/o just not feeling well x 4-5 months since received flu shot in October. Pt called the on call doctor 3/26/19 to make the report. Not that we have seen pt 2x since shot without any c/o.
1 week post administration, developed redness, swelling, warmth, and pain at injection site
consumer reports that pt died in 1989 following DTP/OPV immun; autopsy was performed; no further details available;
I have a fast heart beat with exertion and SOB with exertion.Resting HR 74-80 with minimum exertion like walking around the house  HR goes up to 111-136. Started happening from the time I got the vaccine and has not gone away.
Noticed "rash" on tops thighs and a patch on the back of left thigh. Denies itching, shortness of breath, or difficulty swallowing.